Papyriferic acid derivatives as reversal agents of multidrug resistance in cancer cells

Bioorganic and Medicinal Chemistry

Volumn 18, Issue 8, 2010, Pages 2964-2975

  Xiong, Juan ^a   Taniguchi, Masatoshi ^a   Kashiwada, Yoshiki ^a   Sekiya, Michiko ^b   Yamagishi, Takashi ^c   Takaishi, Yoshihisa ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b NIIGATA UNIVERSITY OF PHARMACY AND APPLIED LIFE SCIENCES   (Japan)

^c KITAMI INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

Betula platyphylla var. japonica; MDR; P Glycoprotein; Papyriferic acid

Indexed keywords

3 O (MORPHOLINO BETA OXOPROPANOYL) 12BETA ACETOXY 3ALPHA,25 DIHYDROXYEPOXYDAMMARANE; COLCHICINE; DAMMARANE DERIVATIVE; PAPYRIFERIC ACID; PAPYRIFERIC ACID DERIVATIVE; UNCLASSIFIED DRUG; VERAPAMIL;

ARTICLE; CANCER RESISTANCE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG SCREENING; HUMAN; HUMAN CELL; MULTIDRUG RESISTANCE;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; HUMANS; MALONATES; MORPHOLINES; P-GLYCOPROTEIN; TRITERPENES;

BETULA PLATYPHYLLA VAR. JAPONICA;

EID: 77950519574     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2010.02.046     Document Type: Article

References (25)

1. Gottesman M.M., Fojo T., and Bates S.E. Nat. Rev. Cancer 2 (2002) 48
2. Szakács G., Paterson J.K., Ludwig J.A., Genthe C.B., and Gottesman M.M. Nat. Rev. Drug Disc. 5 (2006) 219
3. Schinkel A.H., Smit J.J.M., Van Tellingen O., Beijnen J.H., Wagenaar E., Deemter L., van Mol C.A.A.M., Valk M.A., van der Robanus-Maandag E.C., Te Riele H.P.J., Berns A.J.M., and Borst P. Cell 77 (1994) 491
4. Schinkel A.H., Mayer U., Wagenaa E., Mol C.A.A.M., Van Deemter L., Smit J.J.M., Valk M.A., van der Voordouw A.C., Spits H., Van Tellingen O., Zijlmans J.M., Fibbe W.E., and Borst P. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 4028
5. Tian Q., Zhang J., Chan E., Duan W., and Zhou S.F. Drug Dev. Res. 64 (2005) 1
6. Aller S.G., Yu J., Ward A., Weng Y., Chittaboina S., Zhuo R.P., Harrell P.M., Trinh Y.T., Zhang Q.H., Urbatsch I.L., and Geoffrey C. Science 323 (2009) 1718
7. Ling V. Cancer 69 (1992) 2603
8. Ambudkar S.V., Dey S., Hrycyna C.A., Ramachandra M., Pastan I., and Gottesman M.M. Annu. Rev. Pharmacol. Toxicol. 39 (1999) 361
9. Boumendjel A., Baubichon-Cortay H., Trompier D., Perrotton T., and Pietro A.D. Med. Res. Rev. 25 (2005) 453
10. Ozben T. FEBS Lett. 580 (2006) 2903
11. Tsuruo T., Lida H., Tsukagoshi S., and Sakurai Y. Cancer Res. 41 (1981) 1967
12. Futscher B.W., Foley N.E., Guzman M.C.G., Meltzer P.S., and Sullivan D.M. Int. J. Cancer 66 (1996) 520
13. Robert J., and Jarry C. J. Med. Chem. 46 (2003) 4805
14. Relling M.V. Ther. Drug. Monit. 18 (1996) 350
15. Benet L.Z., Cummins C.L., and Wu C.Y. Int. J. Pharm. 277 (2004) 3
16. Kashiwada Y., Sekiya M., Yamazaki K., Ikeshiro Y., Fujioka T., Yamagishi T., Kitagawa S., and Takaishi Y. J. Nat. Prod. 70 (2007) 623
17. Wiese M., and Pajeva I.K. Curr. Med. Chem. 8 (2001) 685
18. Pajeva I.K., and Wiese M. J. Med. Chem. 45 (2002) 5671
19. Ramalhete C., Molnar J., Mulhovo S., Rosario V.E., and Ferreira M.J.U. Bioorg. Med. Chem. 17 (2009) 6942
20. Jiao W., Dong W.W., Li Z.F., Deng M.C., and Lu R.H. Bioorg. Med. Chem. 17 (2009) 4786
21. Stouch T.R., and Gudmundsson O. Adv. Drug Deliv. Rev. 54 (2002) 315
22. Taipale H.T., Vepsalainen J., Laatikainen R., Reichardt P.B., and Lapinjoki S.P. Phytochemistry 34 (1993) 755
23. Prokof'eva N.G., Anisimov M.M., Shentsova E.B., and Pokhilo N.D. Planta Med. 70 (2004) 476
24. Mosmann T. J. Immunol. Methods 65 (1983) 55
25. Carmichael J., Degraff W.G., Gazdar A.F., Minna J.D., and Mitchell J.B. Cancer Res. 47 (1987) 936